Amgen Selling Japanese Rights to Some Drugs
New York Times - 29 minutes ago
By ANDREW POLLACK Biotechnology giant Amgen is selling the Japanese rights to up to 13 of its experimental drugs to Takeda Pharmaceutical of Japan in a deal that might bring Amgen more than $1 billion.
Takeda to Buy Amgen Japan Unit for Up to $902 Million (Update2) Bloomberg
Takeda buys Amgen Japan unit, Japan drug rights Reuters
CNNMoney.com  - Guardian Unlimited  - WELT ONLINE  - InfoBolsa
all 18 news articles